{"actionType":"OPENER","mechanismOfAction":"Vanilloid receptor opener","chemblIds":["CHEMBL112"],"targetName":"Vanilloid receptor","targetType":"single protein","targets":["ENSG00000196689"],"references":[{"source":"PubMed","ids":["15987694","15987694","20862299","12660052","15662292","15987694","17884974","20862299"],"urls":["http://europepmc.org/abstract/MED/15987694","http://europepmc.org/abstract/MED/15987694","http://europepmc.org/abstract/MED/20862299","http://europepmc.org/abstract/MED/12660052","http://europepmc.org/abstract/MED/15662292","http://europepmc.org/abstract/MED/15987694","http://europepmc.org/abstract/MED/17884974","http://europepmc.org/abstract/MED/20862299"]},{"source":"Wikipedia","ids":["Acetaminophen#Mechanism_of_action","Acetaminophen#Mechanism_of_action","Acetaminophen#Mechanism_of_action"],"urls":["http://en.wikipedia.org/wiki/Acetaminophen#Mechanism_of_action","http://en.wikipedia.org/wiki/Acetaminophen#Mechanism_of_action","http://en.wikipedia.org/wiki/Acetaminophen#Mechanism_of_action"]}]}
{"actionType":"BINDING AGENT","mechanismOfAction":"Interleukin-21 binding agent","chemblIds":["CHEMBL4297797"],"targetName":"Interleukin-21","targetType":"single protein","targets":["ENSG00000138684"],"references":[{"source":"Other","ids":["https://acrabstracts.org/abstract/safety-and-tolerability-of-nnc0114%C2%AD0006-an-anti-il-21-monoclonal-antibody-at-multiple-s-c-dose-levels-in-patients-with-rheumatoid-arthritis/"],"urls":["https://acrabstracts.org/abstract/safety-and-tolerability-of-nnc0114%C2%AD0006-an-anti-il-21-monoclonal-antibody-at-multiple-s-c-dose-levels-in-patients-with-rheumatoid-arthritis/"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Beta-2 adrenergic receptor antagonist","chemblIds":["CHEMBL1700","CHEMBL471"],"targetName":"Beta-2 adrenergic receptor","targetType":"single protein","targets":["ENSG00000169252"],"references":[{"source":"Wikipedia","ids":["Sotalol","Sotalol","Sotalol"],"urls":["http://en.wikipedia.org/wiki/Sotalol","http://en.wikipedia.org/wiki/Sotalol","http://en.wikipedia.org/wiki/Sotalol"]},{"source":"DailyMed","ids":["setid=c4caf469-f684-4f6d-98e8-b6a2fff1de98","setid=c4caf469-f684-4f6d-98e8-b6a2fff1de98","setid=c4caf469-f684-4f6d-98e8-b6a2fff1de98"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c4caf469-f684-4f6d-98e8-b6a2fff1de98","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c4caf469-f684-4f6d-98e8-b6a2fff1de98","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c4caf469-f684-4f6d-98e8-b6a2fff1de98"]}]}
{"actionType":"MODULATOR","mechanismOfAction":"Cyclophilin A modulator","chemblIds":["CHEMBL160"],"targetName":"Cyclophilin A","targetType":"single protein","targets":["ENSG00000196262"],"references":[{"source":"FDA","ids":["label/2013/050573s039,050574s047,050625s053lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/050573s039,050574s047,050625s053lbl.pdf"]},{"source":"PubMed","ids":["15879096","18385230","22642569"],"urls":["http://europepmc.org/abstract/MED/15879096","http://europepmc.org/abstract/MED/18385230","http://europepmc.org/abstract/MED/22642569"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Tyrosine-protein kinase JAK2 inhibitor","chemblIds":["CHEMBL603469"],"targetName":"Tyrosine-protein kinase JAK2","targetType":"single protein","targets":["ENSG00000096968"],"references":[{"source":"PubMed","ids":["12010785","10473107","10473107","10473107","17984313","14500395"],"urls":["http://europepmc.org/abstract/MED/12010785","http://europepmc.org/abstract/MED/10473107","http://europepmc.org/abstract/MED/10473107","http://europepmc.org/abstract/MED/10473107","http://europepmc.org/abstract/MED/17984313","http://europepmc.org/abstract/MED/14500395"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Erythropoietin receptor agonist","chemblIds":["CHEMBL2108290"],"targetName":"Erythropoietin receptor","targetType":"single protein","targets":["ENSG00000187266"],"references":[{"source":"Other","ids":["https://www.ema.europa.eu/en/documents/product-information/eporatio-epar-product-information_en.pdf"],"urls":["https://www.ema.europa.eu/en/documents/product-information/eporatio-epar-product-information_en.pdf"]}]}
{"actionType":"BINDING AGENT","mechanismOfAction":"CD166 antigen binding agent","chemblIds":["CHEMBL4297736"],"targetName":"CD166 antigen","targetType":"single protein","targets":["ENSG00000170017"],"references":[{"source":"Other","ids":["https://cancerres.aacrjournals.org/content/79/13_Supplement/212","https://cancerres.aacrjournals.org/content/79/13_Supplement/212"],"urls":["https://cancerres.aacrjournals.org/content/79/13_Supplement/212","https://cancerres.aacrjournals.org/content/79/13_Supplement/212"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Histamine H1 receptor agonist","chemblIds":["CHEMBL1689","CHEMBL770"],"targetName":"Histamine H1 receptor","targetType":"single protein","targets":["ENSG00000196639"],"references":[{"source":"PubMed","ids":["6386273","8487790","6386273","8487790","6386273","8487790"],"urls":["http://europepmc.org/abstract/MED/6386273","http://europepmc.org/abstract/MED/8487790","http://europepmc.org/abstract/MED/6386273","http://europepmc.org/abstract/MED/8487790","http://europepmc.org/abstract/MED/6386273","http://europepmc.org/abstract/MED/8487790"]},{"source":"ISBN","ids":["9780702034718 PP. 12","9780702034718 PP. 12","9780702034718 PP. 12"],"urls":["http://www.isbnsearch.org/isbn/9780702034718","http://www.isbnsearch.org/isbn/9780702034718","http://www.isbnsearch.org/isbn/9780702034718"]},{"source":"DailyMed","ids":["archiveid=232939","archiveid=232939","archiveid=232939"],"urls":["http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=232939","http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=232939","http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=232939"]}]}
{"actionType":"CROSS-LINKING AGENT","mechanismOfAction":"DNA cross-linking agent","chemblIds":["CHEMBL4297474"],"references":[{"source":"PubMed","ids":["31015346"],"urls":["http://europepmc.org/abstract/MED/31015346"]},{"source":"Other","ids":["https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.TPS3658"],"urls":["https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.TPS3658"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"P2X purinoceptor 3 antagonist","chemblIds":["CHEMBL3716057"],"targetName":"P2X purinoceptor 3","targetType":"single protein","targets":["ENSG00000109991"],"references":[{"source":"Other","ids":["http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/887.5"],"urls":["http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/887.5"]},{"source":"PubMed","ids":["24391544"],"urls":["http://europepmc.org/abstract/MED/24391544"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Follicle stimulating hormone receptor agonist","chemblIds":["CHEMBL2108185"],"targetName":"Follicle stimulating hormone receptor","targetType":"single protein","targets":["ENSG00000170820"],"references":[{"source":"PubMed","ids":["19337959","20483664","21850281","26036214"],"urls":["http://europepmc.org/abstract/MED/19337959","http://europepmc.org/abstract/MED/20483664","http://europepmc.org/abstract/MED/21850281","http://europepmc.org/abstract/MED/26036214"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"PI3-kinase p110-alpha subunit inhibitor","chemblIds":["CHEMBL3218576"],"targetName":"PI3-kinase p110-alpha subunit","targetType":"single protein","targets":["ENSG00000121879"],"references":[{"source":"PubMed","ids":["15705718","24170767","15705718","24170767"],"urls":["http://europepmc.org/abstract/MED/15705718","http://europepmc.org/abstract/MED/24170767","http://europepmc.org/abstract/MED/15705718","http://europepmc.org/abstract/MED/24170767"]},{"source":"FDA","ids":["label/2017/209936s000lbl.pdf","label/2017/209936s000lbl.pdf"],"urls":["https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209936s000lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209936s000lbl.pdf"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Androgen Receptor agonist","chemblIds":["CHEMBL1200436"],"targetName":"Androgen Receptor","targetType":"single protein","targets":["ENSG00000169083"],"references":[{"source":"DailyMed","ids":["setid=f622616e-4c11-4149-bf00-5ea5ce97800b"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f622616e-4c11-4149-bf00-5ea5ce97800b"]},{"source":"Wikipedia","ids":["Oxandrolone"],"urls":["http://en.wikipedia.org/wiki/Oxandrolone"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Thyroid stimulating hormone receptor agonist","chemblIds":["CHEMBL1201533"],"targetName":"Thyroid stimulating hormone receptor","targetType":"single protein","targets":["ENSG00000165409"],"references":[{"source":"DailyMed","ids":["setid=b52dfa36-f90b-4e19-9b5e-26db9d04df2b"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b52dfa36-f90b-4e19-9b5e-26db9d04df2b"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"C-X-C chemokine receptor type 4 antagonist","chemblIds":["CHEMBL3545330"],"targetName":"C-X-C chemokine receptor type 4","targetType":"single protein","targets":["ENSG00000121966"],"references":[{"source":"PubMed","ids":["19088012"],"urls":["http://europepmc.org/abstract/MED/19088012"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Tyrosine-protein kinase receptor UFO inhibitor","chemblIds":["CHEMBL3301622"],"targetName":"Tyrosine-protein kinase receptor UFO","targetType":"single protein","targets":["ENSG00000167601"],"references":[{"source":"PubMed","ids":["26555154","28516360","26555154","28516360"],"urls":["http://europepmc.org/abstract/MED/26555154","http://europepmc.org/abstract/MED/28516360","http://europepmc.org/abstract/MED/26555154","http://europepmc.org/abstract/MED/28516360"]},{"source":"Other","ids":["http://meetinglibrary.asco.org/content/131170-144","http://meetinglibrary.asco.org/content/131170-144"],"urls":["http://meetinglibrary.asco.org/content/131170-144","http://meetinglibrary.asco.org/content/131170-144"]},{"source":"FDA","ids":["label/2018/211349s000lbl.pdf","label/2018/211349s000lbl.pdf"],"urls":["https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211349s000lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211349s000lbl.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Acetyl-CoA carboxylase inhibitor","chemblIds":["CHEMBL3359265"],"targetName":"Acetyl-CoA carboxylase","targetType":"protein family","targets":["ENSG00000278540","ENSG00000076555"],"references":[{"source":"Other","ids":["https://cdn.pfizer.com/pfizercom/product-pipeline/February_27_2015_Pipeline_Update_Final2.pdf"],"urls":["https://cdn.pfizer.com/pfizercom/product-pipeline/February_27_2015_Pipeline_Update_Final2.pdf"]},{"source":"PubMed","ids":["33247737"],"urls":["http://europepmc.org/abstract/MED/33247737"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Neurotrophic tyrosine kinase receptor type 2 inhibitor","chemblIds":["CHEMBL3545381"],"targetName":"Neurotrophic tyrosine kinase receptor type 2","targetType":"single protein","targets":["ENSG00000148053"],"references":[{"source":"Other","ids":["http://www.ecmcnetwork.org.uk/sites/default/files/PLX7486%20Background%20for%20CRUK%20Combinations%20Alliance%20(Non-CI)%202015-10-08%20final.pdf","http://www.ecmcnetwork.org.uk/sites/default/files/PLX7486%20Background%20for%20CRUK%20Combinations%20Alliance%20(Non-CI)%202015-10-08%20final.pdf","http://www.ecmcnetwork.org.uk/sites/default/files/PLX7486%20Background%20for%20CRUK%20Combinations%20Alliance%20(Non-CI)%202015-10-08%20final.pdf","http://www.ecmcnetwork.org.uk/sites/default/files/PLX7486%20Background%20for%20CRUK%20Combinations%20Alliance%20(Non-CI)%202015-10-08%20final.pdf"],"urls":["http://www.ecmcnetwork.org.uk/sites/default/files/PLX7486%20Background%20for%20CRUK%20Combinations%20Alliance%20(Non-CI)%202015-10-08%20final.pdf","http://www.ecmcnetwork.org.uk/sites/default/files/PLX7486%20Background%20for%20CRUK%20Combinations%20Alliance%20(Non-CI)%202015-10-08%20final.pdf","http://www.ecmcnetwork.org.uk/sites/default/files/PLX7486%20Background%20for%20CRUK%20Combinations%20Alliance%20(Non-CI)%202015-10-08%20final.pdf","http://www.ecmcnetwork.org.uk/sites/default/files/PLX7486%20Background%20for%20CRUK%20Combinations%20Alliance%20(Non-CI)%202015-10-08%20final.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Epidermal growth factor receptor erbB1 inhibitor","chemblIds":["CHEMBL1201577"],"targetName":"Epidermal growth factor receptor erbB1","targetType":"single protein","targets":["ENSG00000146648"],"references":[{"source":"DailyMed","ids":["setid=8bc6397e-4bd8-4d37-a007-a327e4da34d9"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8bc6397e-4bd8-4d37-a007-a327e4da34d9"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Poly [ADP-ribose] polymerase-1 inhibitor","chemblIds":["CHEMBL3644587"],"targetName":"Poly [ADP-ribose] polymerase-1","targetType":"single protein","targets":["ENSG00000143799"],"references":[{"source":"PubMed","ids":["26513298","32523090","26513298","32523090","26513298","32523090"],"urls":["http://europepmc.org/abstract/MED/26513298","http://europepmc.org/abstract/MED/32523090","http://europepmc.org/abstract/MED/26513298","http://europepmc.org/abstract/MED/32523090","http://europepmc.org/abstract/MED/26513298","http://europepmc.org/abstract/MED/32523090"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Synaptic vesicular amine transporter inhibitor","chemblIds":["CHEMBL1200515"],"targetName":"Synaptic vesicular amine transporter","targetType":"single protein","targets":["ENSG00000165646"],"references":[{"source":"DailyMed","ids":["archiveid=98261"],"urls":["http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=98261"]},{"source":"Wikipedia","ids":["Reserpine"],"urls":["http://en.wikipedia.org/wiki/Reserpine"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Histamine H1 receptor antagonist","chemblIds":["CHEMBL1201068","CHEMBL1201210"],"targetName":"Histamine H1 receptor","targetType":"single protein","targets":["ENSG00000196639"],"references":[{"source":"ISBN","ids":["0443-059748 PP. 240, 529"],"urls":["http://www.isbnsearch.org/isbn/0443059748"]},{"source":"Wikipedia","ids":["Promethazine","Propiomazine"],"urls":["http://en.wikipedia.org/wiki/Promethazine","http://en.wikipedia.org/wiki/Propiomazine"]}]}
{"actionType":"OPENER","mechanismOfAction":"Potassium channel subfamily K member 18 opener","chemblIds":["CHEMBL1257"],"targetName":"Potassium channel subfamily K member 18","targetType":"single protein","targets":["ENSG00000186795"],"references":[{"source":"PubMed","ids":["16402123","16973644","17227289","16402123","16973644","17227289","16402123","16973644","16402123","16973644","17227289","11465594","16402123","16973644","16402123","16973644","17227289","16402123","16973644","17227289"],"urls":["http://europepmc.org/abstract/MED/16402123","http://europepmc.org/abstract/MED/16973644","http://europepmc.org/abstract/MED/17227289","http://europepmc.org/abstract/MED/16402123","http://europepmc.org/abstract/MED/16973644","http://europepmc.org/abstract/MED/17227289","http://europepmc.org/abstract/MED/16402123","http://europepmc.org/abstract/MED/16973644","http://europepmc.org/abstract/MED/16402123","http://europepmc.org/abstract/MED/16973644","http://europepmc.org/abstract/MED/17227289","http://europepmc.org/abstract/MED/11465594","http://europepmc.org/abstract/MED/16402123","http://europepmc.org/abstract/MED/16973644","http://europepmc.org/abstract/MED/16402123","http://europepmc.org/abstract/MED/16973644","http://europepmc.org/abstract/MED/17227289","http://europepmc.org/abstract/MED/16402123","http://europepmc.org/abstract/MED/16973644","http://europepmc.org/abstract/MED/17227289"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Bacterial dihydropteroate synthase inhibitor","chemblIds":["CHEMBL1200351","CHEMBL439"],"targetName":"Bacterial dihydropteroate synthase","targetType":"single protein","targets":[],"references":[{"source":"PubMed","ids":["15673759","9127492"],"urls":["http://europepmc.org/abstract/MED/15673759","http://europepmc.org/abstract/MED/9127492"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Bacterial 70S ribosome inhibitor","chemblIds":["CHEMBL1200688"],"targetName":"Bacterial 70S ribosome","targetType":"protein nucleic-acid complex","targets":[],"references":[{"source":"PubMed","ids":["20876130"],"urls":["http://europepmc.org/abstract/MED/20876130"]},{"source":"DailyMed","ids":["setid=b455bbdb-a3f1-470f-aa5f-ed83ac2e228d#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b455bbdb-a3f1-470f-aa5f-ed83ac2e228d#nlm34090-1"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Potassium-transporting ATPase inhibitor","chemblIds":["CHEMBL1567328","CHEMBL1503"],"targetName":"Potassium-transporting ATPase","targetType":"protein complex","targets":["ENSG00000105675","ENSG00000186009"],"references":[{"source":"FDA","ids":["label/2012/019810s095,022056s011lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019810s095,022056s011lbl.pdf"]},{"source":"PubMed","ids":["10411559","18925391","19120905"],"urls":["http://europepmc.org/abstract/MED/10411559","http://europepmc.org/abstract/MED/18925391","http://europepmc.org/abstract/MED/19120905"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Cytotoxic T-lymphocyte protein 4 inhibitor","chemblIds":["CHEMBL4297876"],"targetName":"Cytotoxic T-lymphocyte protein 4","targetType":"single protein","targets":["ENSG00000163599"],"references":[{"source":"Other","ids":["https://cancerres.aacrjournals.org/content/77/13_Supplement/3654"],"urls":["https://cancerres.aacrjournals.org/content/77/13_Supplement/3654"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Ferriprotoporphyrin IX inhibitor","chemblIds":["CHEMBL1690","CHEMBL1535"],"references":[{"source":"FDA","ids":["label/2007/009768s041lbl.pdf","label/2007/009768s041lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/009768s041lbl.pdf","http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/009768s041lbl.pdf"]},{"source":"Wikipedia","ids":["Hemozoin"],"urls":["http://en.wikipedia.org/wiki/Hemozoin"]},{"source":"PubMed","ids":["17970883","18220957","14967191","17970883","18220957"],"urls":["http://europepmc.org/abstract/MED/17970883","http://europepmc.org/abstract/MED/18220957","http://europepmc.org/abstract/MED/14967191","http://europepmc.org/abstract/MED/17970883","http://europepmc.org/abstract/MED/18220957"]}]}
{"actionType":"RNAI INHIBITOR","mechanismOfAction":"VEGFR1 mRNA rnai inhibitor","chemblIds":["CHEMBL4650436"],"references":[{"source":"PubMed","ids":["32561705"],"urls":["https://pubmed.ncbi.nlm.nih.gov/32561705/"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Platelet-derived growth factor receptor beta inhibitor","chemblIds":["CHEMBL124660"],"targetName":"Platelet-derived growth factor receptor beta","targetType":"single protein","targets":["ENSG00000113721"],"references":[{"source":"PubMed","ids":["12124172","12166950","12124172","12166950","12124172","12166950"],"urls":["http://europepmc.org/abstract/MED/12124172","http://europepmc.org/abstract/MED/12166950","http://europepmc.org/abstract/MED/12124172","http://europepmc.org/abstract/MED/12166950","http://europepmc.org/abstract/MED/12124172","http://europepmc.org/abstract/MED/12166950"]},{"source":"Other","ids":["http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804","http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804","http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804"],"urls":["http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804","http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804","http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"DNA inhibitor","chemblIds":["CHEMBL1201093","CHEMBL1096562"],"references":[{"source":"DailyMed","ids":["setid=d02af310-d097-4886-86e5-adcf6bca0533"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d02af310-d097-4886-86e5-adcf6bca0533"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Arachidonate 5-lipoxygenase inhibitor","chemblIds":["CHEMBL93"],"targetName":"Arachidonate 5-lipoxygenase","targetType":"single protein","targets":["ENSG00000012779"],"references":[{"source":"DailyMed","ids":["setid=9bc08d7b-13da-444f-ac8a-3714a05176cc"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9bc08d7b-13da-444f-ac8a-3714a05176cc"]}]}
{"actionType":"BINDING AGENT","mechanismOfAction":"Mucin-5AC binding agent","chemblIds":["CHEMBL2108708"],"targetName":"Mucin-5AC","targetType":"single protein","targets":["ENSG00000215182"],"references":[{"source":"PubMed","ids":["26187510"],"urls":["http://europepmc.org/abstract/MED/26187510"]}]}
{"actionType":"MODULATOR","mechanismOfAction":"Metabotropic glutamate receptor 5 modulator","chemblIds":["CHEMBL3545164"],"targetName":"Metabotropic glutamate receptor 5","targetType":"single protein","targets":["ENSG00000168959"],"references":[{"source":"PMC","ids":["PMC172159"],"urls":["http://www.ncbi.nlm.nih.gov/pmc/articles/PMC172159/"]},{"source":"PubMed","ids":["22469098"],"urls":["http://europepmc.org/abstract/MED/22469098"]}]}
{"actionType":"BINDING AGENT","mechanismOfAction":"Toxin B binding agent","chemblIds":["CHEMBL2108872"],"targetName":"Toxin B","targetType":"single protein","targets":[],"references":[{"source":"PubMed","ids":["16838228","17206941","18341677","16838228","17206941","18341677"],"urls":["http://europepmc.org/abstract/MED/16838228","http://europepmc.org/abstract/MED/17206941","http://europepmc.org/abstract/MED/18341677","http://europepmc.org/abstract/MED/16838228","http://europepmc.org/abstract/MED/17206941","http://europepmc.org/abstract/MED/18341677"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Complement C3 inhibitor","chemblIds":["CHEMBL4298211"],"targetName":"Complement C3","targetType":"single protein","targets":["ENSG00000125730"],"references":[{"source":"Other","ids":["https://investors.apellis.com/news-releases/news-release-details/apellis-pharmaceuticals-completes-enrollment-phase-3-apl-2"],"urls":["https://investors.apellis.com/news-releases/news-release-details/apellis-pharmaceuticals-completes-enrollment-phase-3-apl-2"]},{"source":"PubMed","ids":["31474439","33464651"],"urls":["http://europepmc.org/abstract/MED/31474439","http://europepmc.org/abstract/MED/33464651"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Hepatocyte growth factor receptor inhibitor","chemblIds":["CHEMBL3989937","CHEMBL3188267"],"targetName":"Hepatocyte growth factor receptor","targetType":"single protein","targets":["ENSG00000105976"],"references":[{"source":"FDA","ids":["label/2020/213591s000lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213591s000lbl.pdf"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Tumor necrosis factor receptor superfamily member 10B agonist","chemblIds":["CHEMBL2107846"],"targetName":"Tumor necrosis factor receptor superfamily member 10B","targetType":"single protein","targets":["ENSG00000120889"],"references":[{"source":"PubMed","ids":["10411544","22914439","10411544","22914439"],"urls":["http://europepmc.org/abstract/MED/10411544","http://europepmc.org/abstract/MED/22914439","http://europepmc.org/abstract/MED/10411544","http://europepmc.org/abstract/MED/22914439"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"DNA inhibitor","chemblIds":["CHEMBL1200981","CHEMBL417"],"references":[{"source":"DailyMed","ids":["setid=0a03c798-a652-4895-b29c-3b521a89ba42#section-14"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0a03c798-a652-4895-b29c-3b521a89ba42#section-14"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"IgG receptor FcRn large subunit p51 inhibitor","chemblIds":["CHEMBL4650514"],"targetName":"IgG receptor FcRn large subunit p51","targetType":"single protein","targets":["ENSG00000104870"],"references":[{"source":"PubMed","ids":["32915379"],"urls":["https://pubmed.ncbi.nlm.nih.gov/32915379/"]}]}
